M. Earle

Activity and metabolism of 2-beta-D-ribofuranosylthiazole-4-carboxamide in human lymphoid tumor cells in culture.

R. Glazer, M. Earle, 1983, Cancer research.

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in patients with refractory metastatic carcinoma.

R. Shadduck, R. Stoller, D. Przepiorka, 1989, Blood.

2'-deoxycoformycin toxicity in murine spleen lymphocytes.

R. Glazer, M. Earle, 1983, Molecular pharmacology.

Low Overexpression of HER-2/Neu in Advanced Colorectal Cancer Limits the Usefulness of Trastuzumab (Herceptin®) and Irinotecan as Therapy. A Phase II Trial

R. Day, Helen X. Chen, S. Finkelstein, 2004, Cancer investigation.

Use of granulocyte-macrophage colony-stimulating factor in patients with malignancy and bone marrow failure.

R. Shadduck, C. Rosenfeld, R. Stoller, 1990, International journal of cell cloning.

Intrahepatic platinum in the treatment of liver metastases from small cell lung cancer.

R. Stoller, S. Jacobs, M. Earle, 1984, Cancer treatment reports.

A phase II study utilizing oxaliplatin and docetaxel in androgen independent prostate cancer in men treated with up to two prior chemotherapy regimens.

L. Brown, G. Chatta, D. Friedland, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Perirectal infections in patients with small cell lung cancer.

J. Minna, P. Bunn, D. Ihde, 1981, JAMA.

A Phase I/II Study of Trimetrexate and Capecitabine in Patients With Advanced Refractory Colorectal Cancer

S. Wieand, T. Richards, K. Matin, 2005, American journal of clinical oncology.

Clinical Pathways: Management of Quality and Cost in Oncology Networks in the Metastatic Colorectal Cancer Setting.

B. O'Neil, A. Barry, K. Lokay, 2017, Journal of oncology practice.

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in patients with refractory metastatic carcinoma.

R. Shadduck, R. Stoller, D. Przepiorka, 1989, Blood.